1.
Arif M, Yi P. APOBEC3 deaminase drives acquired anticancer targeted therapy resistance. tso [Internet]. 2023 Sep. 24 [cited 2024 Jul. 17];1(2):26-9. Available from: https://translsuronco.org/index.php/tso/article/view/8245